PT Phapros, Tbk (PEHA.JK)

IDR 304.0

(-3.21%)

Total Liabilities Summary of PT Phapros, Tbk

PT Phapros, Tbk's latest annual total liabilities in 2023 was 995.56 Billion IDR , down -3.76% from previous year.
PT Phapros, Tbk's latest quarterly total liabilities in 2024 Q3 was 966.13 Billion IDR , down -3.6% from previous quarter.
PT Phapros, Tbk reported annual total liabilities of 1034.46 Billion IDR in 2022, down -5.75% from previous year.
PT Phapros, Tbk reported annual total liabilities of 1097.56 Billion IDR in 2021, down -6.6% from previous year.
PT Phapros, Tbk reported quarterly total liabilities of 966.13 Billion IDR for 2024 Q3, down -3.6% from previous quarter.
PT Phapros, Tbk reported quarterly total liabilities of 990.41 Billion IDR for 2024 Q1, down -0.52% from previous quarter.

Annual Total Liabilities Chart of PT Phapros, Tbk (2023 - 2011)

Historical Annual Total Liabilities of PT Phapros, Tbk (2023 - 2011)

Year	Total Liabilities	Total Liabilities Growth
2023	995.56 Billion IDR	-3.76%
2022	1034.46 Billion IDR	-5.75%
2021	1097.56 Billion IDR	-6.6%
2020	1175.08 Billion IDR	-7.84%
2019	1275.1 Billion IDR	18.19%
2018	1078.86 Billion IDR	127.35%
2017	474.54 Billion IDR	81.67%
2016	261.2 Billion IDR	13.11%
2015	230.93 Billion IDR	0.48%
2014	229.84 Billion IDR	-8.68%
2013	251.69 Billion IDR	37.52%
2012	183.01 Billion IDR	48.29%
2011	123.42 Billion IDR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	1002.21 Billion IDR	1.19%
2024 Q3	966.13 Billion IDR	-3.6%
2024 Q1	990.41 Billion IDR	-0.52%
2023 Q4	995.56 Billion IDR	-8.8%
2023 FY	995.56 Billion IDR	-3.76%
2023 Q2	1065.67 Billion IDR	5.23%
2023 Q1	1012.75 Billion IDR	-2.1%
2023 Q3	1091.57 Billion IDR	2.43%
2022 Q2	1147.26 Billion IDR	-6.89%
2022 FY	1034.46 Billion IDR	-5.75%
2022 Q4	1034.46 Billion IDR	-11.66%
2022 Q3	1171.01 Billion IDR	2.07%
2022 Q1	1232.2 Billion IDR	12.27%
2021 Q4	1097.56 Billion IDR	-5.96%
2021 Q2	1219.74 Billion IDR	0.91%
2021 FY	1097.56 Billion IDR	-6.6%
2021 Q3	1167.06 Billion IDR	-4.32%
2021 Q1	1208.79 Billion IDR	2.87%
2020 Q4	1175.08 Billion IDR	-21.07%
2020 FY	1175.08 Billion IDR	-7.84%
2020 Q3	1488.72 Billion IDR	8.12%
2020 Q2	1376.92 Billion IDR	10.51%
2020 Q1	1246.02 Billion IDR	-2.28%
2019 Q3	1244.55 Billion IDR	6.71%
2019 Q2	1166.29 Billion IDR	-7.57%
2019 Q1	1261.84 Billion IDR	16.96%
2019 FY	1275.1 Billion IDR	18.19%
2019 Q4	1275.1 Billion IDR	2.46%
2018 FY	1078.86 Billion IDR	127.35%
2018 Q4	1078.86 Billion IDR	0.0%
2018 Q1	- IDR	-100.0%
2017 Q4	474.54 Billion IDR	0.0%
2017 FY	474.54 Billion IDR	81.67%
2016 FY	261.2 Billion IDR	13.11%
2015 FY	230.93 Billion IDR	0.48%
2014 FY	229.84 Billion IDR	-8.68%
2013 FY	251.69 Billion IDR	37.52%
2012 FY	183.01 Billion IDR	48.29%
2011 FY	123.42 Billion IDR	0.0%

Peer Total Liabilities Comparison of PT Phapros, Tbk

Name	Total Liabilities	Total Liabilities Difference
PT Darya-Varia Laboratoria Tbk	639.05 Billion IDR	-55.787%
PT Merck Tbk	161.93 Billion IDR	-514.789%
PT Pyridam Farma Tbk	1164.17 Billion IDR	14.483%
PT Industri Jamu dan Farmasi Sido Muncul Tbk	504.76 Billion IDR	-97.232%
PT Tempo Scan Pacific Tbk	3250.09 Billion IDR	69.368%